Biocept [BIOC] vs Thermo Fisher [TMO] Detailed Stock Comparison

Biocept Inc

NASDAQ
Loading...

Thermo Fisher Scientific Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Biocept Inc wins in 4 metrics, Thermo Fisher Scientific Inc. wins in 11 metrics, with 1 ties. Thermo Fisher Scientific Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Biocept Inc Thermo Fisher Scientific Inc. Better
P/E Ratio (TTM) -0.01 25.84 Thermo Fisher Scientific Inc.
Price-to-Book Ratio 1.55 3.31 Biocept Inc
Debt-to-Equity Ratio 39.97 82.91 Biocept Inc
PEG Ratio 0.00 2.29 Tie
EV/EBITDA -0.01 19.02 Thermo Fisher Scientific Inc.
Profit Margin (TTM) -9.99% 15.15% Thermo Fisher Scientific Inc.
Operating Margin (TTM) -123.69% 17.89% Thermo Fisher Scientific Inc.
EBITDA Margin (TTM) N/A 17.89% N/A
Return on Equity -362.16% 13.52% Thermo Fisher Scientific Inc.
Return on Assets (TTM) -103.93% 5.00% Thermo Fisher Scientific Inc.
Free Cash Flow (TTM) $-14.10M $6.29B Thermo Fisher Scientific Inc.
Dividend Yield N/A 0.38% N/A
1-Year Return 0.00% 16.53% Thermo Fisher Scientific Inc.
Price-to-Sales Ratio (TTM) 0.04 3.86 Biocept Inc
Enterprise Value $354,060 $214.76B Thermo Fisher Scientific Inc.
EV/Revenue Ratio 0.01 4.75 Biocept Inc
Gross Profit Margin (TTM) -332.94% N/A N/A
Revenue per Share (TTM) $46 $120 Thermo Fisher Scientific Inc.
Earnings per Share (Diluted) $-56.70 $18.18 Thermo Fisher Scientific Inc.
Beta (Stock Volatility) N/A 0.97 N/A
Short % of Float N/A 1.22% N/A

Biocept Inc vs Thermo Fisher Scientific Inc. Stock Performance Analysis

Loading Price Chart...

BIOC
TMO

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Biocept Inc769.80%N/AN/AN/AN/AN/A
Thermo Fisher Scientific Inc.0.93%0.87%8.07%0.79%-17.74%-20.05%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Biocept Inc0.00%0.00%0.00%-100.00%-90.75%-90.23%
Thermo Fisher Scientific Inc.16.53%-12.65%-2.72%220.94%654.32%1,231.84%

Performance & Financial Health Analysis: Biocept Inc vs Thermo Fisher Scientific Inc.

MetricBIOCTMO
Market Information
Market Cap i$1.14M$174.55B
Market Cap CategoryMicro capLarge cap
10 Day Avg. Volume i402,7162,356,220
90 Day Avg. Volume i205,8092,071,517
Last Close$0.43$473.72
52 Week Range$0.00 - $0.49$385.46 - $643.99
% from 52W High-11.26%-26.44%
All-Time High$270,540.00 (Feb 03, 2014)$672.34 (Dec 27, 2021)
% from All-Time High-100.00%-29.54%
Growth Metrics
Quarterly Revenue Growth-0.12%0.06%
Quarterly Earnings GrowthN/A0.10%
Financial Health
Profit Margin (TTM) i-0.10%0.15%
Operating Margin (TTM) i-1.24%0.18%
Return on Equity (TTM) i-3.62%0.14%
Debt to Equity (MRQ) i39.9782.91
Cash & Liquidity
Book Value per Share (MRQ)$0.28$141.96
Cash per Share (MRQ)$6.40$8.75
Operating Cash Flow (TTM) i$-13,221,000$8.29B
Levered Free Cash Flow (TTM) i$-32,087,000$5.51B
Dividends
Last 12-Month Dividend Yield iN/A0.38%
Last 12-Month Dividend iN/A$1.76

Valuation & Enterprise Metrics Analysis: Biocept Inc vs Thermo Fisher Scientific Inc.

MetricBIOC (Apr 30, 2025)TMO (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i-0.0125.84
Forward P/E i-0.3217.16
PEG Ratio i0.002.29
Price to Sales (TTM) i0.043.86
Price to Book (MRQ) i1.553.31
Market Capitalization
Market Capitalization i$1.14M$174.55B
Enterprise Value i$354,060$214.76B
Enterprise Value Metrics
Enterprise to Revenue i0.014.75
Enterprise to EBITDA i-0.0119.02
Risk & Other Metrics
Beta iN/A0.97
Book Value per Share (MRQ) i$0.28$141.96

Financial Statements Comparison: Biocept Inc vs Thermo Fisher Scientific Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBIOC (2022)TMO (2025)
Revenue/Sales i25.86M44.56B
Cost of Goods Sold i28.44M26.32B
COGS % of Revenue i110.0%59.1%
Gross Profit i-2.58M18.24B
Gross Margin i-10.0%40.9%
Research & Development i6.16M1.40B
Operating Income (EBIT) i-31.98M8.11B
Operating Margin i-123.7%18.2%
EBITDA i-31.98M11.86B
EBITDA Margin i-123.7%26.6%
Pre-Tax Income i-32.21M7.31B
Pre-Tax Income % of Revenue i-124.6%16.4%
Income Tax i-125,000547.00M
Income Tax % of Revenue i-0.5%1.2%
Net Income (Profit) i-32.09M6.72B
Profit Margin i-124.1%15.1%

Balance Sheet & Liquidity Metrics

MetricBIOC (2022)TMO (2025)
Cash & Equivalents i12.90M9.85B
Total Current Assets i16.34M28.71B
Total Current Assets % of Revenue i63.2%64.4%
Total Current Liabilities i5.51M15.19B
Total Current Liabilities % of Revenue i21.3%34.1%
Long-Term Debt i10.38M35.85B
Long-Term Debt % of Revenue i40.1%80.5%
Total Shareholders Equity i8.86M53.54B
Retained Earnings i-298.44M59.16B
Retained Earnings % of Revenue i-1,154.1%132.8%
Property, Plant & Equipment i14.14M0

Cash Flow Statement Comparison

MetricBIOC (2022)TMO (2025)
Operating Cash Flow i-13.22M7.82B
Operating Cash Flow % of Revenue i-51.1%17.5%
Capital Expenditures i-807,000-1.48B
Free Cash Flow i-14.10M6.29B
FCF Margin i-54.5%14.1%
Debt Repayment i-1.31M-3.51B
Common Stock Repurchase iN/A-3.00B

Short Interest & Institutional Ownership Analysis

MetricBIOCTMO
Shares Short iN/A4.54M
Short Ratio iN/A2.38
Short % of Float iN/A1.22%
Shares Outstanding i2.63M371.62M
Float Shares iN/A371.07M
% Held by Insiders iN/A0.17%
% Held by Institutions iN/A95.23%
% Held by Public iN/A4.60%

Dividend Analysis & Yield Comparison: Biocept Inc vs Thermo Fisher Scientific Inc.

MetricBIOCTMO
Last 12-Month Dividend iN/A$1.76
Last 12-Month Dividend Yield iN/A0.38%
3-Year Avg Annual Dividend iN/A$1.60
3-Year Avg Dividend Yield iN/A0.08%
3-Year Total Dividends iN/A$4.80
Ex-Dividend DateN/AMar 13, 2026